White House Announces Deal to Provide 150 Million Rapid Coronavirus Tests
The $760 million agreement is for 150 million rapid coronavirus tests called BinaxNOW made by Abbott Laboratories.
Read More
Search Results for: point-of-care
POC Diagnostics and “Super Bacteria”
Moving diagnostic technology to the clinical setting is key to the fight against antibiotic resistance.
Read MoreFDA EUA Issued for LumiraDx Covid-19 Antigen Test
FDA has authorized the covid-19 antigen test for use in high and moderate complexity laboratories certified under CLIA and at the point of care.
Read More
miR Scientific Noninvasive Prostate Cancer Test Validation Published
miR Scientific’s urine-based, noninvasive cancer test can detect molecular evidence of prostate cancer with sensitivity of 94% and specificity of 92%.
Read More
Blood Test May Point to Higher Risk for Covid-19 Death
Elevated levels of these five biomarkers were associated with inflammation and bleeding disorder as well as increased risk of death in covid-19 patients.
Read More